Abstract:Objective:To screen for the Echinococcus granulosus 01883（Eg-01883） specifically expressed at the protoscolex period, clone and express this molecule as well as analyse its immunogenicity.Methods:Eg-01883, which is highly expressed at the protoscolex period but not in oncosphere， was screened by analysing the published mRNA sequences of E. granuolosus. Total RNA of E. granuolosus was extracted, Eg-01883 was cloned by RT-PCR, and the recombinant plasmid pET28a-Eg-01883 was constructed. Expression of the recombinant protein rEg-01883 was induced by isopropyl-β-D-thiogalactoside （IPTG）. ICR mice were randomized into 3 groups （n=12 in each group）. Mice in the immunization group received subcutaneous injections of 10 μg rEg-01883 in 100 μl PBS emulsified in Freund’s adjuvant at multiple sites, followed by immune enhancement after 2 weeks. Mice in the adjuvant group were injected with PBS and adjuvant. Mice in the control group received no treatment. Blood was obtained through caudal vein before immunization, and at 1, 2, and 4 weeks after the first immunization, and through the eyeball at 6 weeks after immunization. Serum levels of IgG, IFN-γ and IL-4 were determined by ELISA. The immunogenicity of rEg-01883 was identified by Western blotting.Results:Eg-01883 was screened, cloned, expressed and purified to obtain the recombinant protein rEg-01883, which mainly existed as the inclusion body. ELISA results showed that immunization with rEg-01883 induced production of specific IgG antibody. The serum IgG level in the immunization group increased from 1 week after the first immunization, peaked at 6 weeks（2.344±0.153）, which was significantly higher than those of the adjuvant group（0.206 1±0.006） and the control group （0.241±0.01）（P<0.01）. At 6 weeks after the first immunization, the serum levels of IFN-γ （43.23 pg/ml） and IL-4（24.88 pg/ml） in the immunization group were significantly higher than those in the adjuvant group（21.77 pg/ml, 13.27 pg/ml） and the control group（17.40 pg/ml, 12.25 pg/ml）（P<0.05）. Western blot showed that the recombinant protein rEg-01883 could be recognized by His-Tag antibodies, serum of immunized mice, and serum of mice with secondary infection.Conclusion:The recombinant protein rEg-01883 shows good immunogenicity in ICR mice.

Cloning and prokaryotic expression of EG95 gene of Echinococcus granulosus oncospheres

Cloning Sequencing of Eg95 Antigen Gene and Construction of Pcdna3-Eg95

Cloning and expression of EG19 gene of Echinococcus granulosus and reactionogenicity of recombinant protein

Construction and identification of the recombinant plasmid pET30a-EgA31-Eg95 of Echinococcus granulosus

Prokaryotic Expression and Identification of Eg95 Gene from Echinococcus Granulosus in Sheep

Cloning, expression, and immunoreactivity analysis of antigen Eg-08002 from protoscoleces of Echinococcus granulosus

Cloning and Expression of Echinococcus Granulosus Eg18 and Preliminary Evaluation of Immunological Assay with Recombinant Antigen

[Cloning, Expression and Immunodiagnostic Evaluation of Antigen EPC1 from Echinococcus Granulosus].

Cloning, expression, purification and identification of EgG1Y162-2 gene from Echinococcus granulosus

Cloning and sequence analyzing of vaccine candidated gene EG95 from Echinococcus granulosus

[Construction, Identification, and Expression of Lactococcus lactis-Based Recombinant Vaccine for Echinococcus granulosus]

Construction of the Recombinant Plasmid Pet30a-Ega31 of Echinococcus Granulosus and Its Induced Expression in E. Coli.

Identification of Combined T-cell and B-cell Reactive Echinococcus Granulosus 95 Antigens for the Potential Development of a Multi-Epitope Vaccine

Prokaryotic Expression and Identification of B- and T-cell Combined Epitopes of Em95 Antigen of Echinococcus Multilocularis.

[Cloning, expression and bioinformatics analysis of cyclophilin of Echinococcus granulosus].

Cloning, Expression and Immungenicity Analysis of Antigen Eg-01883 Screened from Protoscoleces of Echinococcus Granulosus

Construction of the Recombinant Plasimid pET30a-EgA31 of Echinococcus Granulosus and Its Induced Expression in E.coil

Cloning, Fusion Expression and Identification of Gene Encoding the Thioredoxin Peroxidase from Echinococcus Granulosus

Construction of the Recombinant Secretion Type BCG-Eg95 Vaccine of Echinococcus Granulosus

Expression and Serological Evaluation of the Protective Antigen Eg95 Recombinant Protein of Echinococcus Granulosus.

Prokaryotic Expression and Immunologic Identification of AgB8/2 Gene from Echinococcus granulosus